Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma

References

• Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma – United States, 1980–1999. MMWR Surveill Summ 2002;51(1):1–13
   PubMed Web of Science ®Google Scholar
• Woolcock AJ, Peat JK. Evidence for the increase in asthma worldwide. Ciba Found Symp 1997;206:122–34
   PubMedGoogle Scholar
• Yunginger JW, Reed CE, O’Connell EJ, et al. A community-based study of the epidemiology of asthma. Incidence rates, 1964–1983. Am Rev Respir Dis 1992;146: 888–94
   Google Scholar
• Croner S, Kjellman N-IM. Natural history of bronchial asthma in childhood: a prospective study from birth up to 12–14 years of age. Allergy 1992;47: 150–7
   Google Scholar
• Burrows B, Knudson RJ, Cline MG, Lebowitz MD. A reexamination of risk factors for ventilatory impairment. Am Rev Respir Dis 1988;138:829–36
   PubMed Web of Science ®Google Scholar
• Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. New Engl J Med 1995;332:133–8
   PubMed Web of Science ®Google Scholar
• Martinez FD. Recognizing early asthma. Allergy 1999;54\(Suppl. 49):24–8
   Google Scholar
• Carlsen KH. What distinguishes the asthmatic amongst the infant wheezers? Pediatr Allergy Immunol 1997;8(Suppl 10):40–5
   PubMedGoogle Scholar
• Krawiec ME, Wescott JY, Chu HW, et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. Am J Respir Crit Care Med 2001;163: 1338–43
   PubMed Web of Science ®Google Scholar
• Sheriff A, Peters TJ, Henderson J, Strachan D, ALSPAC Study Team. Avon Longitudinal Study of Parents and Children. Risk factor associations with wheezing patterns in children followed longitudinally from birth to 3(1/2) years. Int J Epidemiol 2001;30(6):1473–84
   Google Scholar
• Rusconi F, Galassi C, Corbo GM, et al. Risk factors for early, persistent, and late-onset wheezing in young children. Am J Respir Crit Care Med 1999;160:1617–22
   PubMed Web of Science ®Google Scholar
• Kaur B, Anderson HR, Austin J, et al. Prevalence of asthma symptoms, diagnosis, and treatment in 12–14 year old children across Great Britain (international study of asthma and allergies in childhood, ISAAC UK). Br Med J 1998;316:118–24
   PubMed Web of Science ®Google Scholar
• Grant EN, Daugherty SR, Moy JN, et al. Prevalence and burden of illness for asthma and related symptoms among kindergartners in Chicago public schools. Ann Allergy Asthma Immunol 1999;83:113–20
   PubMed Web of Science ®Google Scholar
• Busse WW. The role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy 1996;26:868–79
   PubMed Web of Science ®Google Scholar
• Laitinen LA, Laitinen A, Haahtela T, et al. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 1993;341:989–90
   PubMed Web of Science ®Google Scholar
• Dahlen SE, Hedquist P, Hammerstrom B, Samuelsson B. Leukotrienes are potent constrictors of human bronchii. Nature 1980;288:484–6
   PubMed Web of Science ®Google Scholar
• Drazen JM, Israel E, O’Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. New Engl J Med 1999;340:197–206.
   PubMed Web of Science ®Google Scholar
• Cohen P, Noveral JP, Bhaia A, et al. Leukotriene D4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis. Am J Physiol 1995;269:L151–L157
   PubMed Web of Science ®Google Scholar
• Smith CM, Hawksworth RJ, Thein FC, et al. Urinary leukotriene-E4 in bronchial asthma. Eur Respir J 1992;5:693–9
   PubMed Web of Science ®Google Scholar
• Cowburn AS, Sladek K, Soja J, et al. Over expression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101:834–46
   PubMed Web of Science ®Google Scholar
• Azevedo I, de Blic J, Scheinmann P, et al. Enhanced arachidonic acid metabolism in alveolar macrophages from wheezy infants. Am J Respir Crit Care Med 1995;152:1208–14
   PubMed Web of Science ®Google Scholar
• Reiss TF, Chervinsky P, Dockhorn RJ, et al. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma. Arch Intern Med 1998;158(11):1213–20
   PubMed Web of Science ®Google Scholar
• Israel E, Chervinsky PS, Friedman B, et al., for the Montelukast Beclomethasone Comparison Study Group. Effects of montelukast and beclomethasone on airway function and asthma control. J Allergy Clin Immunol 2002;110:847–54
   Google Scholar
• Price DB, Hernandez D, Magyar P, et al., for the Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy (COMPACT) International Study Group. Randomized controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003;58:211–6
   Google Scholar
• Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. J Am Med Assoc 1998;279:1181–96
   PubMed Web of Science ®Google Scholar
• Bisgaard H, for the Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379–83
   PubMed Web of Science ®Google Scholar
• Becker A, Swern A, Tozzi CA, et al. Montelukast in asthmatic patients 6 years–14 years old with an FEV1 > 75%. Curr Med Res Opin 2004;20:1651–9
   PubMed Web of Science ®Google Scholar
• Garcia MLG, Wahn U, Gilles L, et al. Montelukast compared to fluticasone in control of asthma in 6 to 14 year old patients with mild asthma: The MOSAIC study. Pediatrics (in press)
   Google Scholar
• Bisgaard H, Garcia MLG, Zielen S, et al. Montelukast reduces viral induced asthma exacerbations in 2 to 5 year old children with intermittent asthma. Am J Respir Crit Care Med 2005;171:315–22
   PubMed Web of Science ®Google Scholar
• Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001;108(3):E48
   PubMed Web of Science ®Google Scholar
• Storms W, Michele TM., Knorr B, et al. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ³ 6 years. Clin Exp Allergy 2001;31:77–87
   PubMed Web of Science ®Google Scholar
• Global initiative for asthma. Pocket guide for asthma management and prevention. NIH Publication No. 96–3659B. Bethesda (MD): National Institutes of Health; 1998
   Google Scholar
• Migoya E, Kearns GL, Hartford A, et al. Pharmacokinetics of montelukast in asthmatic patients 6 to < 24 months old. J Clin Pharm 2004;44:487–94
   PubMed Web of Science ®Google Scholar
• Klug B, Bisgaard H. Specific airway resistance, interrupter resistance, and respiratory impedance in healthy children aged 2–7 years. Pediatr Pulmonol 1998;25:322–31
   PubMed Web of Science ®Google Scholar
• Ducharme FM, Davis GM. Measurement of respiratory resistance in the emergency department. Chest 1997;111:1519–25
   PubMed Web of Science ®Google Scholar
• Castro-Rodriguez JA, Holberg CJ, Morgan WJ, et al. Relation of two different subtypes of croup before age three to wheezing, atopy, and pulmonary function during childhood: a prospective study. Pediatrics 2001;170:512–8
   Google Scholar
• Martinez FD, Helms PJ. Types of asthma and wheezing. Eur Respir J 1998;12\(Suppl. 27):3S–8S
   Google Scholar